Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Accenture
UBS
Chubb
Daiichi Sankyo
Novartis
Cantor Fitzgerald
US Army
Harvard Business School
Baxter

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020430

« Back to Dashboard

NDA 020430 describes ORGARAN, which is a drug marketed by Aspen Global Inc and is included in one NDA. Additional details are available on the ORGARAN profile page.

The generic ingredient in ORGARAN is danaparoid sodium. There is one drug master file entry for this compound. Additional details are available on the danaparoid sodium profile page.
Summary for 020430
Tradename:ORGARAN
Applicant:Aspen Global Inc
Ingredient:danaparoid sodium
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength750 UNITS/0.6ML
Approval Date:Dec 24, 1996TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Harvard Business School
Boehringer Ingelheim
Accenture
Healthtrust
Chinese Patent Office
Johnson and Johnson
Baxter
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot